Recently, by activating the ROS-p38 MAPK pathway, Chiba et al. [123] indicated that a small molecule inhibitor of ALDH (disulfiram) had been shown to downregulate the bulk of CSC markers and suppress the self-renewal ability of HCC cells. This evidence concerns the gene LDHA and hepatocellular carcinoma.